News
-
-
-
-
-
PRESS RELEASE
Biophytis unveils Phase 2 Obesity Trial Strategy with BIO101 in Europe and Brazil
Biophytis unveils Phase 2 Obesity Trial Strategy for BIO101 in Europe and Brazil, targeting muscle wasting associated with obesity. The new program broadens potential and value-creation opportunities globally -
-
-
-
-
PRESS RELEASE
Wildpack Releases Second Quarter Financial Results and Provides Update on the Proposed Debenture Restructuring Transaction, Strategic Alternatives, and Financial Advisor Appointment
Wildpack Beverage Inc. announces Q2 2025 financial results, debenture restructuring progress, strategic alternatives evaluation, and financial advisor engagement